BMS-986504 demonstrates sturdy responses in MTAP-deleted NSCLC, together with EGFR and ALK-positive tumors
Credit score: CC0 Public Area BMS-986504, a first-in-class methylthioadenosine (MTA)-cooperative protein arginine…
Aumolertinib + chemotherapy improves progression-free survival in NSCLC: Scientific trial
Credit score: Pixabay/CC0 Public Area New outcomes from the ACROSS 2 Section…
Trial exhibits osimertinib plus chemotherapy improves general survival in EGFR-mutated superior NSCLC
Credit score: Pixabay/CC0 Public Area Ultimate general survival (OS) outcomes from the…
Zidesamtinib exhibits sturdy responses in ROS1 TKI pre-treated NSCLC
Credit score: RDNE Inventory mission from Pexels Zidesamtinib, an investigational next-generation ROS1…
Ivonescimab + chemotherapy improves progression-free survival in sufferers with EGFR+ NSCLC
Credit score: Anna Tarazevich from Pexels Including ivonescimab, a first-in-class bispecific antibody…
Nivolumab maintains high quality of life and reduces symptom deterioration in resectable NSCLC, trial exhibits
Credit score: Pixabay/CC0 Public Area An evaluation from the Section III CheckMate…
New antibody-drug conjugate reveals promising efficacy in EGFR-mutated NSCLC sufferers
Credit score: CC0 Public Area A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1),…
